EXELIXIS, INC.
Biological Products, (No Diagnostic Substances) · 1851 HARBOR BAY PARKWAY, ALAMEDA, CA 94502
官方登记数据
0位关注者
1994成立于
关于 EXELIXIS, INC.
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部1851 HARBOR BAY PARKWAY, ALAMEDA, CA 94502
成立1994
法律形式C Corporation
状态营业中
专利1295 项专利
AGENTS THAT BIND TO NKG2A AND PD-L1 AND USES THEREOFUS20260226161A1 · 2026
NKG2A BINDING AGENTS AND USES THEREOFUS20260226162A1 · 2026
关键数据
法律信息
| 法定名称 | EXELIXIS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 939767在 SEC EDGAR 上查看 ↗ |
| EIN | 04-3257395 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 1851 HARBOR BAY PARKWAY, ALAMEDA, CA 94502 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026